Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.70 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA4 | P22748 | 1/20 | 0.44 |
| ▸ | NOS3 | P29474 | 3/20 | 0.43 |
| ▸ | NOS1 | P29475 | 3/20 | 0.43 |
| ▸ | NOS2 | P35228 | 3/20 | 0.43 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.38 |
| ▸ | SHBG | P04278 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL128915 | 1.00 | — | — | |
| SCHEMBL11227844 | 1.00 | CYP1A2 (0.70) | CYP1A2SIGMAR1CA1CA2CA4 | |
| SCHEMBL7738781 | 1.00 | CYP1A2 (0.70) | CYP1A2SIGMAR1CA1CA2CA4 | |
| SCHEMBL27988307 | 1.00 | CYP1A2 (0.70) | CYP1A2SIGMAR1CA1CA2CA4 | |
| SCHEMBL3633846 | 1.00 | CYP1A2 (0.70) | CYP1A2SIGMAR1CA1CA2CA4 | |
| SCHEMBL11726232 | 1.00 | CYP1A2 (0.70) | CYP1A2SIGMAR1CA1CA2CA4 | |
| SCHEMBL97288 | 1.00 | CYP1A2 (0.70) | CYP1A2SIGMAR1CA1CA2CA4 | |
| SCHEMBL7741556 | 1.00 | CYP1A2 (0.70) | CYP1A2SIGMAR1CA1CA2CA4 | |
| Ammonia Solution, Strong SCHEMBL2254142 | 0.97 | CYP1A2 (0.67) | CYP1A2SIGMAR1CA1CA2CA4 | |
| Methane SCHEMBL16670259 | 0.97 | CYP1A2 (0.67) | CYP1A2SIGMAR1CA1CA2CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 144 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109647199-A | A kind of preparation method of reverse osmosis membrane and thus obtained reverse osmosis membrane | 时代沃顿科技有限公司 | 2019-04-19 | — | — | CN | claimed |
| CN-114682102-B | Reverse osmosis membrane and preparation method thereof | 沃顿科技股份有限公司 | 2023-06-27 | — | — | CN | disclosed |
| EP-4114825-A1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2023-01-11 | — | — | EP | disclosed |
| CN-114682102-A | Reverse osmosis membrane and preparation method thereof | 沃顿科技股份有限公司 | 2022-07-01 | — | — | CN | disclosed |
| EP-3999183-A1 | COMPOUND HAVING KDM5 INHIBITORY ACTIVITY AND PHARMACEUTICAL USE THEREOF | Ono Pharmaceutical Co., Ltd. (JP) | 2022-05-25 | — | — | EP | disclosed |
| CN-109790284-B | Polyphenol compound and process for producing the same | 三菱化学株式会社 | 2021-09-21 | — | — | CN | disclosed |
| WO-2021175855-A1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2021-09-10 | — | — | WO | disclosed |
| CN-112892249-A | Polyamide reverse osmosis membrane and preparation method thereof | 时代沃顿科技有限公司 | 2021-06-04 | — | — | CN | disclosed |
| WO-2021010492-A1 | COMPOUND HAVING KDM5 INHIBITORY ACTIVITY AND PHARMACEUTICAL USE THEREOF | ONO PHARMACEUTICAL CO., LTD. (JP) | 2021-01-21 | — | — | WO | disclosed |
| US-10851039-B2 | Polyhydric phenol compound and method of producing same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2020-12-01 | — | — | US | disclosed |
| US-5314970-A | Block and graft copolymers; compatibilizing agents | ELF ATOCHEM NORTH AMERICA, INC. (US) | 1994-05-24 | — | — | US | disclosed |
| US-5025048-A | Oxygen resistant, storage-stable curable polysiloxanes hydrosilated by a polycyclic polyene and a compound containing an amine and a hydroxy, both sterically hindered | HERCULES INCORPORATED (US) | 1991-06-18 | — | — | US | disclosed |
| EP-0024943-B1 | 5,6,7-TRINOR-4,8-INTER-M-PHENYLENE PGI2 DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | TORAY INDUSTRIES, INC. (JP) | 1983-08-17 | — | — | EP | disclosed |
| US-4331683-A | SENSITIZATION, ANTIALLERGENS | PFIZER INC. (US) | 1982-05-25 | — | — | US | disclosed |
| US-4301164-A | FOR USE AS ANTIULCER AGENTS, HYPOTENSIVE AGENTS, ANTITHROMBOSIC AGENTS | TORAY INDUSTRIES, INC. (JP) | 1981-11-17 | — | — | US | disclosed |
| EP-0024943-A1 | 5,6,7-Trinor-4,8-inter-m-phenylene PGI2 derivatives and pharmaceutical compositions containing them | TORAY INDUSTRIES, INC. (JP) | 1981-03-11 | — | — | EP | disclosed |
| US-4226999-A | ANTIOXIDANTS FOR POLYMERS | CIBA-GEIGY CORPORATION (US) | 1980-10-07 | — | — | US | disclosed |
| US-4202816-A | ENOL-PIPERIDINE METAL COMPLEXES | CIBA-GEIGY CORPORATION (US) | 1980-05-13 | — | — | US | disclosed |
| US-4198334-A | HEAT, LIGHT, OXIDATION RESISTANCE, PLASTICS | CIBA-GEIGY CORPORATION (US) | 1980-04-15 | — | — | US | disclosed |
| US-4148784-A | HEAT, LIGHT AND OXIDATION RESISTANCE FOR SYNTHETIC POLYMERS | CIBA-GEIGY CORPORATION (US) | 1979-04-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10851039-B2 | Polyhydric phenol compound and method of producing same | RB1, FHIT, H1-4 | CYP1A2 426/4885SIGMAR1 1009/4885CA1 1421/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.